In the kidney, miRNA-192-5p contributes to protection against hypertension through the target gene ATP1B1 (β1 subunit of Na+/K+-ATPase), and miR-192-5p levels are significantly decreased in humans with hypertension or hypertensive nephrosclerosis [66]. Here, ATP1B1 is linked to hypertensive disorder.